Cargando…
Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases
Expansion of polyglutamine (polyQ) tracts in proteins results in protein aggregation and is associated with cell death in at least nine neurodegenerative diseases. Disease age of onset is correlated with the polyQ insert length above a critical value of 35–40 glutamines. The aggregation kinetics of...
Autores principales: | Khare, Sagar D, Ding, Feng, Gwanmesia, Kenneth N, Dokholyan, Nikolay V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1193989/ https://www.ncbi.nlm.nih.gov/pubmed/16158094 http://dx.doi.org/10.1371/journal.pcbi.0010030 |
Ejemplares similares
-
Polyglutamine Induced Misfolding of Huntingtin Exon1 is Modulated by the Flanking Sequences
por: Lakhani, Vinal V., et al.
Publicado: (2010) -
Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease
por: Sugaya, Keizo, et al.
Publicado: (2012) -
The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases
por: Popiel, H. Akiko, et al.
Publicado: (2011) -
Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020) -
Molecular dynamics analysis of the aggregation propensity of polyglutamine segments
por: Wen, Jingran, et al.
Publicado: (2017)